Upcoming FDA Medical Device Sterilization Town Hall: Sterility Master Files
September 9, 2024- On Sept. 11 from 1-2 p.m. ET, the FDA will host a virtual Medical Device Sterilization Town Hall: Sterility Master Files and Effective…
JHC’s Dail-eNews
Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk
September 9, 2024- About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their…
New data shows BD needle-free connectors demonstrate better clinical outcomes
September 9, 2024-BD announced new data that shows certain BD needle-free connectors demonstrated decreased risk for central venous catheter intraluminal blood occlusions (CVC-IBO) and central…
New study supports annual breast cancer screening for women over 40
September 6, 2024- Women diagnosed with breast cancer who had regular screening mammograms every year were less likely to have late-stage cancer and had higher overall survival than those…
Abbott’s Lingo™ Continuous Glucose Monitor for Health and Wellness now available in the U.S.
September 6, 2024- Abbott announced U.S. availability of Lingo™, the company’s first continuous glucose monitoring system available without a prescription. The Lingo system includes a…
BD completes acquisition of Critical Care from Edwards Lifesciences
September 6, 2024- BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient…
Lung health: Youth E-Cigarette use drops to lowest level in a decade
September 6, 2024- Half a million fewer U.S. youth reported current use of e-cigarettes in 2024 compared to 2023, according to new data from the…
Walgreens to participate in TD Cowen’s 9th Annual FutureHealth Conference
September 6, 2024- Walgreens announced that Ramita Tandon, Chief Clinical Trials Officer, will deliver a keynote presentation at TD Cowen’s 9th Annual FutureHealth Conference, Tuesday, Sept. 10, at 4:10 p.m….
Abbott initiates clinical study to evaluate the use of its deep brain stimulation system
September 5, 2024- Abbott announced it has initiated a clinical trial, called the TRANSCEND study, to evaluate the use of the company’s deep brain stimulation…
One month left to register for JHC’s IDN Insights West
September 5, 2024- Please join The Journal of Healthcare Contracting at IDN Insights West October 9-10 at Arizona State University. Meet with Banner Health, HonorHealth,…